Sondhi Dolan — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Sondhi Dolan has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Sondhi Dolan is a person listed in Passage Bio, Inc.'s SEC filings as having a leadership or governance role with the company as of the filing date 2026-05-21. Passage Bio is a biotechnology company focused on gene therapies for rare genetic diseases. Publicly available biographical information about Dolan is limited based on the provided SEC context, and the exact title and responsibilities are not disclosed in these materials. There is no indication in the SEC filings that Dolan is deceased as of the most recent filing date.
Role
Insider
Notability
40/100
Board memberships
Passage Bio, Inc.
Awards & honors
Listed in Passage Bio, Inc. SEC filings (2026-05-21) in relation to the company's leadership/governance context
Sondhi Dolan is a person listed in Passage Bio, Inc.'s SEC filings as having a leadership or governance role with the company as of the filing date 2026-05-21. Passage Bio is a biotechnology company focused on gene therapies for rare genetic diseases. Publicly available biographical information about Dolan is limited based on the provided SEC context, and the exact title and re…
How many SEC Form 4 filings has Sondhi Dolan submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Sondhi Dolan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
